Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Odyssey Health (ODYY) EPS (Weighted Average and Diluted) (2021 - 2026)

Odyssey Health has reported EPS (Weighted Average and Diluted) over the past 1 years, most recently at -$0.03 for Q3 2021.

  • For Q3 2021, EPS (Weighted Average and Diluted) changed N/A year-over-year to -$0.03; the TTM value through Jul 2021 reached -$0.18, changed N/A, while the annual FY2025 figure was -$0.02, 100.0% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2021 was -$0.03 at Odyssey Health, up from -$0.13 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at -$0.03 in Q3 2021 and troughed at -$0.13 in Q2 2021.